Literature DB >> 2224368

Further investigation of the predictors of outcome following first schizophrenic episodes.

E C Johnstone1, J F Macmillan, C D Frith, D K Benn, T J Crow.   

Abstract

The outcome at two years of patients who were eligible for a study of first schizophrenic episodes was assessed in terms of occupation (n = 237) and in terms of number of days spent as an in-patient from the time of first admission (n = 252), and was related to social, behavioural, mental state and neurological measures during the initial admission. Poor outcome was in general associated with more social withdrawal, inactivity and abnormal social presentation and with more 'neurological soft signs'. Good occupational outcome in patients with a relatively short pre-treatment duration of illness was associated with the prescription of placebo medication during the follow-up period.

Entities:  

Mesh:

Year:  1990        PMID: 2224368     DOI: 10.1192/bjp.157.2.182

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  22 in total

1.  Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.

Authors:  Andreas Wittorf; Georg Wiedemann; Gerhard Buchkremer; Stefan Klingberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

Review 2.  The effects of early and sustained intervention on the long-term morbidity of schizophrenia.

Authors:  R J Wyatt; I D Henter
Journal:  J Psychiatr Res       Date:  1998 May-Aug       Impact factor: 4.791

Review 3.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

4.  A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-up.

Authors:  John F M Gleeson; Sue M Cotton; Mario Alvarez-Jimenez; Darryl Wade; Donna Gee; Kingsley Crisp; Tracey Pearce; Daniela Spiliotacopoulos; Belinda Newman; Patrick D McGorry
Journal:  Schizophr Bull       Date:  2011-11-29       Impact factor: 9.306

5.  A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

Authors:  Martin Harrow; Thomas H Jobe; Robert N Faull; Jie Yang
Journal:  Psychiatry Res       Date:  2017-06-22       Impact factor: 3.222

6.  Neurological soft signs in schizophrenia: assessment and correlates.

Authors:  F Mohr; W Hubmann; R Cohen; W Bender; C Haslacher; S Hönicke; R Schlenker; C Wahlheim; P Werther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

7.  Medication adherence for children and adolescents with first-episode psychosis following hospitalization.

Authors:  Robin E Gearing; Alice Charach
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-04-21       Impact factor: 4.785

Review 8.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

9.  Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology.

Authors:  Konasale M Prasad; Richard Sanders; John Sweeney; Debra Montrose; Vaibhav Diwadkar; Diana Dworakowski; Jean Miewald; Matcheri Keshavan
Journal:  Schizophr Res       Date:  2008-12-23       Impact factor: 4.939

10.  Developmental and neurologic correlates of treatment response in schizophrenia.

Authors:  C L Whelton; J M Cleghorn; S Atley; G J Durocher; D MacCrimmon
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.